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Two cDNA clones (3.7 kb and 4.8 kb) encoding a Drosophila muscarinic acetylcholine receptor were isolated from a 
Drosophila head cDNA library and characterized by automated DNA sequence analysis. The Drosophila muscarinic re- 
ceptor contains 788 amino acids with a calculated h4, of 84 807 and displays greater than 60% homology with mammalian 
muscarinic receptors. The muscarinic receptor maps to the tip of the right arm of the second chromosome of the Drosophi- 
la genome. 
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1. INTRODUCTION 
Muscarinic acetylcholine receptors have been 
shown to be members of a supergene family that in- 
cludes adrenergic receptors and opsins (see [l-3] 
for review). The most striking structural feature of 
all of these proteins is the presence of 7 regions of 
hydrophobic amino acids that are presumed to 
represent membrane spanning helices [2,3]. Based 
on gene cloning and sequence analysis, 5 distinct 
mammalian muscarinic acetylcholine receptor sub- 
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types have been identified and expression studies 
have demonstrated that each of these receptor sub- 
types displays unique pharmacological and bio- 
chemical responses [4- 121. 
A number of studies have provided evidence for 
muscarinic acetylcholine receptors in lower phyla, 
particularly in molluscs and arthropods (see [13] 
for a review). Limited proteolysis of affinity label- 
ed Drosophila muscarinic acetylcholine receptors 
suggested considerable conservation of receptor 
structure between mammalian and insect receptors 
[ 14,151. Here we describe the cloning and sequence 
analysis of a cDNA coding for a Drosophila 
muscarinic acetylcholine receptor. As predicted 
from earlier biochemical, pharmacological and im- 
munological data [14-171, this receptor exhibits a 
high degree of structural homology to mammalian 
muscarinic receptors. 
2. MATERIALS AND METHODS 
2.1. Library screening 
A cDNA library in lambda zap was obtained from Dr. 
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Thomas Schwarz (Howard Hughes Medical Institute, Stanford 
University School of Medicine). The library was made from po- 
ly A’ mRNA isolated from the heads of the Oregon-R strain of 
Drosophila mdanogaster. The library was plated at a density of 
approximately 5 x 104 plaques per 150 mm plate (lo6 plaques 
total) using the bacterial host strain BB4 and was probed with 
a “P-radiolabeled 0.8 kb Taql fragment of a rat M2 muscarinic 
acetylcholine receptor cDNA clone containing bases 22-856 
which correspond to amino acids 2-286 [5]. The probe was 
radiolabeled using random primer extension to a specific activi- 
ty of > lo9 dpm/,ug DNA. Hybridization was carried out for 
16 h at 42°C in a solution containing 6 x SSC (1 x SSC = 0.15 
M NaCl, 0.015 M sodium citrate, pH 7.0), 5 x Denhardt’s olu- 
tion, 10 fig/ml sheared, heat-denatured salmon sperm DNA, 
30% formamide (deionized) and 50 mM sodium phosphate, pH 
7.4. Filters were washed with 6x SSC/O.l% SDS for 15 min at 
room temperature, 2x SSC for 15 min at room temperature, 
and 1 x SSC for 15 min at room temperature plus 10 min at 
42”C, dried and autoradiographed overnight at - 70°C using 
Kodak X-Omat AR5 film. 
2.2.Preparation of cDNA clones for DNA sequencing 
Positive lambda zap clones containing cDNA inserts were 
amplified in vivo as plasmids as described by Stratagene, Inc. 
(La Jolla, CA). cDNA fragments were removed from each clone 
using EcoRl, the ends of each fragment were filled in using 
Klenow DNA polymerase and subcloned into the Smal site of 
pVZ1 [18]. Insert orientations were determined by restriction 
digest analysis. Opposite orientations of each fragment in pVZ1 
were isolated for use in DNA sequencing. Restriction digest 
analysis indicated that there were no internal Asp718 or Sac1 
sites in the insert fragments. Therefore, these enzymes were used 
to linearize the pVZ1 subclones prior to exonuclease III diges- 
tion which creates a series of deletions for use in sequencing. Ex- 
onuclease III deletion generation was carried out according to 
the strategy of Henikoff [19]. At 30 s intervals, aliquots were 
removed from exonuclease III reactions and blunt ends were 
created with Si nuclease and DNA polymerase. The partially 
deleted plasmids were ligated and used to transform the 
bacterial host strain, BSJ72. Overlapping deletion subclones 
were amplified and the appropriate inserts were selected for se- 
quencing based on their mobilities on agarose gels. 
2.3. DNA sequencing 
Single-stranded DNA was rescued from cells transformed 
with pVZ1 deletion plasmids by superinfection with Ml3K07 
(Promega, Inc., Madison, WI). The single-stranded DNA was 
used as a template for dideoxy sequencing as described by 
Sanger et al. [20] using modified T7 (Sequenase) polymerase and 
fluorescent dye primers with an Applied Biosystems 370A DNA 
sequencer [5]. 
2.4. Chromosome localization 
The 4.8 kb EcoRI Drosophila cDNA insert was biotinylated 
using the BRL nick translation system and biotin-1 1-dUTP (En- 
zo Chemical). It was hybridized to larval salivary gland polytene 
chromosomes and detected using the BRL BluGENE detection 
system according to the procedure described by Engels et al. 
WI. 
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3. RESULTS AND DISCUSSION 
3.1. DNA cloning and sequencing 
A Drosophila head cDNA library was screened 
using a 0.8 kb TaqI probe derived from a cDNA 
clone encoding a rat M2 muscarinic acetylcholine 
receptor [5]. Initial positive clones were rescreened 
twice using the same probe. Two positive clones 
were excised from lambda zap as plasmids and 
characterized further. Restriction endonuclease 
digest analysis of these clones indicated that one 
contained a 3.7 kb EcoRI insert, the second con- 
tained a 4.8 kb EcoRI insert. The EcoRI inserts of 
the two clones were subcloned into pVZ1 for DNA 
sequence analysis which revealed that they were 
overlapping clones displaying significant homology 
with mammalian muscarinic acetylcholine recep- 
tors. The 3.7 kb cDNA clone lacked a complete 5 ’ 
coding region which was found in the 4.8 kb cDNA 
clone. The sequencing strategies for the 3.7 kb and 
4.8 kb cDNA inserts are illustrated in fig.lA. The 
complete nucleotide sequence of these cDNA 
clones is illustrated in fig.lB. 
The 4.8 kb Drosophila cDNA clone contains a 
single, large open reading frame that extends from 
an initiation codon (ATG) at bases l-3 to a ter- 
mination codon (TAG) at bases 2362-2364 (fig. 1 B) 
and codes for a protein of 788 amino acids with a 
calculated molecular weight of 84 807. There are, 
however, other possible candidate initiation 
codons within the 5’ sequence of this cDNA clone. 
Further experiments will be necessary to identify 
the actual initiation codon. The amino acid se- 
quence of the Drosophila receptor shows a high 
degree of sequence homology with mammalian 
muscarinic acetylcholine receptors (fig.2), strongly 
suggesting that this cDNA codes for a Drosophila 
muscarinic acetylcholine receptor. The Drosophila 
muscarinic receptor displays approximately 60% 
homology with mammalian muscarinic receptors 
(Ml: 69%, M2: 64070, M3: 62%, M4: 64% and MS: 
64%) when the entire sequence is compared and 
favored amino acid substitutions are considered. 
The transmembrane domains have a higher degree 
of amino acid homology with a maximum of 88% 
in transmembrane domains III and IV (fig.2). 
This Drosophila receptor contains several 
features that are characteristic of the 
muscarinic/adrenergic receptor supergene family. 
There are 3 potential sites for N-linked glycosyla- 
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tion (Asn-X-Ser or Thr) as seen in the other cloned 
muscarinic receptors at Asn-65, -84 and -87 in the 
Drosophila sequence. Furthermore, the Drosophila 
protein contains 3 aspartic acids in the putative se- 
cond and third transmembrane spanning helices 
that are conserved in all members of this gene fami- 
ly known to bind amine ligands [22,23]. All but one 
of the cysteine residues found in mammalian 
muscarinic receptors is conserved in the Drosophila 
muscarinic receptor. 
The predicted hydropathy plot of the Drosophila 
receptor is illustrated in fig.3 and is compared to 
those of mammalian muscarinic acetylcholine 
receptors. As seen in mammalian muscarinic recep- 
tors, the Drosophila receptor contains 7 stretches 
of hydrophobic amino acids that most likely repre- 
sent transmembrane spanning domains. In addi- 
tion, the Drosophila receptor also contains a 
stretch of hydrophobic residues at its amino ter- 
minus that is similar in its hydropathy to signal se- 
0 100 200 300 400 500 600 700 800 
RESIDUE 
DROSOPHILR MUSCRRINIC 
RAT Ml MUSCRRINIC 
RRT M2 MUSCRRINIC 
RAT M3 MUSCRRINIC 
Fig.3. Hydropathy analysis of Drosophifa and mammalian muscarinic acetylcholine receptors. Hydropathy plots of Kyte and Doolittle 
[32] were calculated using a window of 20 residues for the Drosophila muscarinic receptor or for rat Ml-M3 muscarinic acetylcholine 
receptors [4,5]. Conserved hydrophobic regions presumed to represent transmembrane spanning domains are indicated by the arrows. 
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Fig.4. Chromosome localization of the Drosophila muscarinic 
receptor gene. In situ hybridization of the biotinylated cDNA 
insert to salivary gland chromosomes was detected .by binding 
steptavidin-coupled alkaline phosphatase to the hybridized 
clone and then detecting the binding by the presence of a colored 
precipitate formed by the action of alkaline phosphatase. The 
position of the colored band is indicated by the arrow. Direct 
examination of the chromosomes howed that the hybridization 
was proximal (i.e., closer to the centromere) to the dark band 
which defines the start of the 60 Da region. 
quences in other membrane proteins [24] but is not 
found in mammalian muscarinic receptors. 
Cleavage of the protein in this region would leave 
a mature protein containing glycosylation sites very 
close to the amino terminal end of the protein, as 
is seen in mammalian muscarinic receptors; 
however, there is no evidence as yet for such a 
cleavage. The Drosophila receptor also contains a 
significantly longer intracellular loop between 
putative transmembrane segments V and VI than 
do any of the mammalian receptors. The amino 
acid sequence of this region of the Drosophila 
muscarinic receptor shows little similarity to any of 
the corresponding sequences found in mammalian 
muscarinic receptors. 
3.2.Chromosome localization 
To determine where this putative muscarinic 
receptor maps in the Drosophila genome, the 
biotinylated cDNA was hybridized to Drosophila 
salivary gland polytene chromosomes. As shown in 
fig.4, the probe hybridized to a single site at the tip 
of the right arm of chromosome 2 in the region of 
6OC5-8. This muscarinic receptor gene maps to the 
right (i.e., is farther from the centromere) of the 
seizure locus which affects saxitoxin binding to the 
voltage-sensitive sodium channel [25]. The musca- 
rinic receptor gene maps to the left of a gene cloned 
on the basis of its high homology to voltage- 
sensitive sodium channels [26]. Thus, there appear 
to be a number of interesting, neuronally expressed 
genes in this chromosome region. Studies are in 
progress to determine whether any of the known 
mutations which map to this general region repre- 
sent the muscarinic receptor and whether this is the 
only gene coding for muscarinic receptors in 
Drosophila. 
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